Amazon Rolls Out National GLP-1 Program

April 21, 2026

An article summarized by Axios:

Amazon’s healthcare unit One Medical is launching a nationwide program centered on GLP-1 weight-loss drugs like Ozempic and Wegovy, aiming to capitalize on surging demand. The move comes as major players, including Walmart, race into the fast-growing obesity treatment market, which is rapidly reshaping how weight care is delivered.

One Medical says its approach differs from many telehealth providers by integrating GLP-1 treatments into broader primary care. The program includes regular check-ins, lab work, and ongoing monitoring, with clinicians adjusting treatment based on a patient’s overall health, including conditions like diabetes or high blood pressure. Executives say this model addresses growing concerns that some patients using standalone telehealth services are being under-monitored or improperly treated.

The program is available nationwide across more than 200 locations and connects directly with Amazon Pharmacy for pricing transparency and home delivery. Costs can range from as low as $25 per month with insurance to a few hundred dollars for cash-pay options. Looking ahead, Amazon is betting that combining medication with long-term care, nutrition, and lifestyle support will lead to better outcomes as the GLP-1 market continues to expand with new drugs, formats, and broader access.